NSCLC tumors produce substantial amounts of the chemokine CXCL13, and an intelligent design would be to express its single receptor CXCR5 on the CAR T cells for enhanced CAR T cell tumor infiltration and heightened efficiency. Here, CXCR5 is linked to non-small cell lung carcinoma.